Anita Wiseth
Human Resources Officer bei ONCTERNAL THERAPEUTICS, INC.
Profil
Anita Wiseth is currently the Senior Vice President-Human Resources at Oncternal Therapeutics, Inc. She previously worked as the Senior Director-Human Resources at X-Ceptor Therapeutics, Inc. and as the Director-Human Resources at Sequana Therapeutics, Inc. from 1994 to 1998.
Additionally, she held the position of Vice President-Human Resources at Halozyme Therapeutics, Inc. from 2006 to 2015.
Aktive Positionen von Anita Wiseth
| Unternehmen | Position | Beginn |
|---|---|---|
| ONCTERNAL THERAPEUTICS, INC. | Human Resources Officer | 01.03.2021 |
Ehemalige bekannte Positionen von Anita Wiseth
| Unternehmen | Position | Ende |
|---|---|---|
| HALOZYME THERAPEUTICS, INC. | Human Resources Officer | 01.01.2015 |
Sequana Therapeutics, Inc.
 Sequana Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Sequana Therapeutics Inc. is a leading genomics company that uses industrial-scale gene-finding technologies and functional genomics to develop products aimed at diagnosing and treating common human diseases | Human Resources Officer | 02.01.1998 |
X-Ceptor Therapeutics, Inc.
 X-Ceptor Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services X-Ceptor is a privately held biopharmaceutical company focusing on research in the rapidly developing field of orphan nuclear receptors that serve as the molecular targets for the discovery of novel small molecule pharmaceutical products for the treatment of human diseases. X-Ceptor has developed an integrated approach to drug discovery drawing from their in-house expertise in biology, chemistry and high-throughput screening. X-Ceptor's advantage lies in its understanding of orphan nuclear receptors and their signaling pathways, as well as its proprietary ability to employ these orphan nuclear receptors in transcriptional and biochemical based assays to discover novel therapeutic agents | Human Resources Officer | - |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 2 |
|---|---|
| HALOZYME THERAPEUTICS, INC. | Health Technology |
| ONCTERNAL THERAPEUTICS, INC. | Health Technology |
| Private Unternehmen | 2 |
|---|---|
Sequana Therapeutics, Inc.
Sequana Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Sequana Therapeutics Inc. is a leading genomics company that uses industrial-scale gene-finding technologies and functional genomics to develop products aimed at diagnosing and treating common human diseases | Commercial Services |
X-Ceptor Therapeutics, Inc.
X-Ceptor Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services X-Ceptor is a privately held biopharmaceutical company focusing on research in the rapidly developing field of orphan nuclear receptors that serve as the molecular targets for the discovery of novel small molecule pharmaceutical products for the treatment of human diseases. X-Ceptor has developed an integrated approach to drug discovery drawing from their in-house expertise in biology, chemistry and high-throughput screening. X-Ceptor's advantage lies in its understanding of orphan nuclear receptors and their signaling pathways, as well as its proprietary ability to employ these orphan nuclear receptors in transcriptional and biochemical based assays to discover novel therapeutic agents | Commercial Services |
